Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5021 |  CRIS Curis, Inc. - Common Stock | 1.54 USD | -2.53% | -15.85% | -70.44% | -8.88% | 3.22 M USD | ||
| 5024 |  GNPX Genprex, Inc. - Common Stock | 3.95 USD | 0.00% | -3.89% | -49.10% | +111.23% | 3.24 M USD | ||
| 5028 |  ARTL Artelo Biosciences, Inc. - Common Stock | 0.69 USD | 0.00% | -11.54% | -32.35% | -42.50% | 3.17 M USD | ||
| 5034 |  MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.20 USD | 0.00% | -13.04% | -45.95% | -67.74% | 2.94 M USD | ||
| 5040 |  XRTX XORTX Therapeutics Inc. - Common Shares | 1.88 USD | -7.84% | -14.93% | -6.47% | +129.27% | 2.62 M USD | ||
| 5050 |  ONCO Onconetix, Inc. - Common Stock | 0.64 USD | -1.54% | -17.95% | -23.81% | -15.79% | 2.53 M USD | ||
| 5055 |  SPRC SciSparc Ltd. - Ordinary Shares | 6.74 USD | +0.90% | +6.14% | +41.60% | +51.80% | 2.46 M USD | ||
| 5059 |  OGEN Oragenics Inc. Common Stock | 0.52 USD | 0.00% | -5.45% | 0.00% | -17.46% | 2.35 M USD | ||
| 5061 |  CDT CDT Equity Inc. - Common Stock | 2.76 USD | -3.50% | -6.12% | -10.68% | +64.29% | 2.17 M USD | ||
| 5064 |  SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.39 USD | 0.00% | -4.88% | -83.12% | -75.78% | 2.17 M USD | ||
| 5079 |  VRAX Virax Biolabs Group Limited - Ordinary Shares | 3.15 USD | -1.25% | +11.31% | -0.94% | +320.00% | 1.82 M USD | ||
| 5091 |  PPBT Purple Biotech Ltd - American Depositary Shares | 1.52 USD | -3.18% | +4.11% | +9.35% | +162.07% | 1.41 M USD | ||
| 5092 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 4.58 USD | -1.93% | +0.66% | -0.87% | -8.76% | 1.39 M USD | ||
| 5098 |  SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.02 USD | -6.21% | +1158.33% | +1213.04% | +297.37% | 1.05 M USD | ||
| 5143 |  KTTAW Pasithea Therapeutics Corp. - Warrant | 0.0068 USD | 0.00% | +13.33% | -2.86% | -65.83% | 227.22 K USD | ||
| 5154 |  BDRX Biodexa Pharmaceuticals plc - American Depositary Shares | 1.21 USD | -4.72% | -22.93% | -25.77% | -13.57% | 109.30 K USD | ||
| 5167 |  CMND Clearmind Medicine Inc. - Common Shares | 1.70 USD | -2.30% | -10.53% | +5.59% | +66.67% | 26.87 K USD | ||
| 5196 |  GMAB Genmab A/S - American Depositary Shares | 32.88 USD | -1.70% | +0.52% | +14.17% | +33.55% | 0 USD | ||
| 5228 |  OCS Oculis Holding AG - Ordinary shares | 12.92 USD | -1.30% | -0.84% | +15.36% | -27.42% | 0 USD | ||
| 5241 |  ANL Adlai Nortye Ltd - American Depositary Shares | 13.98 USD | +2.04% | +8.29% | +9.48% | +757.67% | 0 USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |